跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAPENTADOL RETARD SANDOZ 150 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TAPENTADOL RETARD SANDOZ 150 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Approved
STANDARD
TAPENTADOL RETARD SANDOZ 150 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 22, 2022
Approval ID
37c5b64a64dbaec9
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
37c5b64a64dbaec9
Drug Cima Aemps Name
TAPENTADOL RETARD SANDOZ 150 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Register Number
88311
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2022-11-22
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Estupefacientes
Commercialized
Yes
Company Name
Sandoz Farmaceutica S.A.
Active Ingredients
TAPENTADOL FOSFATO
229,70 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 22, 2022
Approval ID
37c5b64a64dbaec9
Type
Standard
Back to CIMA-AEMPS Approvals